secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2025-08-12T23:59:59+00:00
Accession:  0001641172-25-023189
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Oncotelic Therapeutics enters consulting agreements with Jefferson Capital and Valor Nation for strategic services
--------------------------------------------------------------------------------

- Engaged Jefferson Capital Ventures and Valor Nation for 18-month consulting and advisory services starting August 6, 2025.
- Jefferson receives $20,000/month cash and up to 20,320,930 restricted stock awards tied to milestones: market cap >$100M, $10M equity increase, uplisting.
- Valor receives 4,064,586 shares of common stock immediately upon signing.
- Jefferson's RSAs vest in thirds per milestone; unvested shares forfeited if milestones not achieved.
- Shares issued under Section 4(a)(2) exemption from Securities Act registration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000164117225023189/0001641172-25-023189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000164117225023189/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-023189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer